Contact
For business, media, or testing-related inquiries, please get in touch.
Frequently Asked Questions
- Our patent-pending technology, C-POLAR™, is applied to materials during the manufacturing process. The application of C-POLAR™ creates a stable and even positive charge coating across the material surface.
- Because pathogens are negatively charged, the positively charged C-POLAR™ material is able to capture the pathogen.
- Studies and commercial installations demonstrate C-POLAR™ treated materials effectively capture up to 99.99% of pathogens.
- C-POLAR™ has been tested by many reputable international organizations, including Massachusetts General Hospital, Harvard Medical School, University of British Columbia, Czech Academy of Sciences, University of Minnesota, and Hong Kong Metropolitan University.
- Testing focused on C-POLAR™’s effectiveness at capturing different viruses and pathogens, safety / cytotoxicity, and performance when applied to conventional filters in fast airflow environments.
In addition, C-POLAR™ has established a partnership with the UK National Health Service (NHS) through the Northumbria Healthcare NHS Foundation Trust. We have also established a research partnership with the University of British Columbia, with support from Interior Health Canada.
|
Application |
Testing institution |
Result |
|
C-POLAR™ material |
Hong Kong Metropolitan University |
C-POLAR™ material demonstrates effectiveness of up to 99.9999% against S. aureus, E. coli, P. aeruginosa after accelerated aging of 64 days at 60 Celsius, equivalent to real-time aging of 2.4 years. |
|
Silicone protected by C-POLAR™ |
Harvard Medical School, Massachusetts General Hospital |
Reduction of >90-99% in nearly all cases of less pathogen sticking to the silicone formulation protected by C-POLAR™ |
|
C-POLAR™ material |
Harvard Medical School, Massachusetts General Hospital |
Capturing of 92% of S. aureus, with similar effects for E. faecalis, Pseudomonas, and E. coli. The input amount was around 100x higher than the amount required by the ISO 20743 standard. |
|
C-POLAR™ material |
Czech Academy of Sciences |
C-POLAR™ material captured 99.6% of COVID-19 (98% within 5 minutes). One biological replicate achieved 100% capture rate. |
|
Filters protected by C-POLAR™ |
Hong Kong Metropolitan University |
Across seven testing sites, filters protected by C-POLAR™ demonstrated strong microbial capture rate up to 99.999% with up to 7 months of intensive commercial use. |
|
Filters protected by C-POLAR™ |
University of Minnesota |
Filters protected by C-POLAR™ shows 99.3% capture rate of airborne bovine coronavirus in a fast airflow environment. |
|
Face masks protected by C-POLAR™ |
Hong Kong Metropolitan University |
FFP2 and FFP3 face masks protected by C-POLAR™ demonstrate 99.999% effectiveness at capturing microbial particles. |
Yes, C-POLAR™ is safe.
- C-POLAR™ is created using a non-toxic, non-metallic, polymer that is approved by the FDA, World Health Organization and the United Nations Food and Agricultural Organizations.
- Additional testing from the Czech Academy of Sciences and the Hong Kong Metropolitan University have also demonstrated that C-POLAR™ treated materials are safe for humans.
- C-POLAR™ is a versatile technology, with numerous addressable markets and potential product applications. To date, we have 30 products commercialized or in development, and have identified over 200 specific applications for C-POLAR™.
- Our most market-ready products are air filters (fan coil filters, pleated filters, and bag filters used in HVAC systems), truck cabin filters, replacement air purifier filters (installed in air purifiers), and FFP2 and FFP3 face masks.
- An additional 30+ items are currently in development, which include medical personal protective wear (PPW™) (e.g., lab coats, patient gowns), catheters and other medical devices, room furnishings (e.g., hospital curtains, bedding), and water filters.
|
HARVARD MEDICAL SCHOOL |
“C-POLAR™ treated material demonstrates the capture of a wide variety of pathogens. The utilization of C-POLAR™ is an essential interrupter, breaking the chain of infectious spread, reducing infection in many applications while improving overall health.” Dr. Michael K. Mansour |
|
NORTHUMBRIA HEALTHCARE NHS FOUNDATION TRUST |
“Our initial partnership [with C-POLAR Technologies] is a great step towards enabling us to use C-POLAR™ to create safer environments, from ambulances to hospital wards, that are consistently free from pathogens, while providing income back to the public sector” Andrew Edmunds, Director of Innovation |
|
AFL-CIO |
“When we tested C-POLAR™ at our HQ in Washington DC, the results were astonishing, greatly reducing particulates, microorganisms and pollen, and providing a far safer environment for our workers.” James V. Hart President, Metal Trades Department |
|
MIAMI INTERNATIONAL AIRPORT |
“The C-POLAR™ installation was placed in the building that houses me and my executive staff. We are very satisfied [with C-POLAR™] and can attest first-hand that the air quality in Building 3030 has improved significantly.” Isaac Smith Assistant Director, Miami-Dade Aviation Department |
|
TYNESIDE SURGICAL SERVICES (Independent Provider of NHS care) |
“The [C-POLAR™ protected facility] will be the first of a kind, a complete facility that protects our staff and patients from further infection and minimizes the risk of any infection typically caught in healthcare settings.” Hamdy Ashour Founder and Managing Director |
|
GRAND HYATT HOTEL |
“We at Grand Hyatt are honored to be one of the first hotels in Hong Kong to install C-POLAR™ air filter to protect our guests and staff.” Tenny Kwok Director of Engineering |
|
JONES LANG LASALLE |
“JLL’s current building management portfolio [in HK] exceeds over 400 buildings. We will recommend the installation of C-POLAR™ air filter within them all.” C.H. Chung Head of Property Management & Executive Director |
|
HANG LUNG PROPERTIES |
“We are pleased to be one of the first in Hong Kong to install C-POLAR™ air filters at our medical hubs. These measures will offer extra protection to our customers, tenants and employees.” Helen Lau Head of Hong Kong Business Operation |
|
HONG KONG BAPTIST HOSPITAL |
“We are excited to further enhance our protection through using proven technology [such as C-POLAR™].” Grace Wong General Manager |